Paroxysmal nonepileptic events in pediatric patients

Eu Gene Park1, Jiwon Lee1, Bo Lyun Lee2

  • 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Insights

Pediatric paroxysmal nonepileptic events (PNEs) show age-specific patterns, with physiologic symptoms in younger children and psychogenic seizures in older ones. Long-term video-EEG monitoring aids diagnosis.

Area of Science:

  • Pediatric Neurology
  • Clinical Neurophysiology

Background:

  • Paroxysmal nonepileptic events (PNEs) are common in children, but data on their characteristics in pediatric populations, particularly without neurological disorders, are limited.
  • Understanding age-specific PNE presentations is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To evaluate and compare the characteristics of PNEs in pediatric patients across different age groups.
  • To investigate the influence of neurologic deficits on PNE types in children and adolescents.
  • To enhance the early detection and diagnosis of PNEs in pediatric populations.

Main Methods:

  • Retrospective review of 887 pediatric patients admitted to an epilepsy monitoring unit.
  • Diagnosis of PNEs based on clinical history and long-term video-electroencephalography (VEM) monitoring.
  • Patients categorized into three age groups: <6 years, 6-<12 years, and 12-<18 years.

Main Results:

  • Physiologic disorders (e.g., normal infant behavior, sleep movements) were more frequent in children <6 years.
  • Psychogenic nonepileptic seizures predominated in patients >6 years.
  • Vasogenic syncope was common in adolescents; no significant difference in PNE types was found between patients with or without neurologic deficits.

Conclusions:

  • Age-specific patterns of PNEs are evident in pediatric patients, with physiologic events in younger children and psychogenic seizures in older ones.
  • Clinical pattern recognition based on age is vital for diagnosing pediatric PNEs.
  • Long-term VEM is valuable for diagnosing conditions like normal infant behavior and psychogenic nonepileptic seizures in children.
Abstract

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.3K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
388
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
811
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
496